Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.8M | 7.8M | 7.6M | 7.6M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 3.3M | 3.7M | 3.1M | 3.1M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.9M | 2.4M | 2.3M | 2.2M |
| Tax provision | 392K | 830K | 531K | 475K |
| Net income | 1.5M | 1.6M | 1.7M | 1.7M |
| Basic EPS | 0.4 | 0.5 | 0.5 | 0.5 |
| Diluted EPS | 0.4 | 0.5 | 0.5 | 0.5 |
| Basic average shares | 3.5M | 3.5M | 3.5M | 3.5M |
| Diluted average shares | 3.5M | 3.5M | 3.5M | 3.5M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.5M | 1.6M | 1.7M | 1.7M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |